LOCAL ADVANCED RECTAL CANCER
Clinical trials for LOCAL ADVANCED RECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCAL ADVANCED RECTAL CANCER trials appear
Sign up with your email to follow new studies for LOCAL ADVANCED RECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy combo may boost rectal cancer treatment
Disease control Not yet recruitingThis phase III trial is testing whether adding two immunotherapy drugs (iparomlimab and tuvonralimab) to standard chemotherapy after short-course radiation can improve outcomes for people with a specific type of locally advanced rectal cancer (pMMR/MSS). Participants receive eith…
Matched conditions: LOCAL ADVANCED RECTAL CANCER
Phase: PHASE3 • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Two-Drug combo aims to wipe out rectal cancer before surgery
Disease control Not yet recruitingThis trial investigates whether adding two targeted drugs—tafolecimab and sintilimab—to standard chemoradiation can improve outcomes for people with locally advanced rectal cancer that has not spread. Participants receive short-course radiation followed by chemotherapy plus immun…
Matched conditions: LOCAL ADVANCED RECTAL CANCER
Phase: PHASE3 • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC